Cynthia Sirard
CIK 1808408 · View on SEC EDGAR ↗
First SEC filing: April 6, 2020 · Latest: April 6, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | CMPX | A | 1,000,000 | — | — | 1,000,000 Direct | — | Acquired | (price as of 2026-08-21) |
| March 28, 2025 | CYPH | M | 22,500 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| March 28, 2025 | CYPH | M | 22,500 | — | — | 27,500 Direct | +450.00% | Acquired | (price as of 2026-08-21) |
| Oct. 2, 2024 | CYPH | A | 85,000 | — | — | 85,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 29, 2024 | CYPH | A | 85,000 | — | — | 85,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 26, 2024 | CYPH | M | 5,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Jan. 26, 2024 | CYPH | M | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 23, 2023 | CYPH | A | 70,000 | — | — | 70,000 Direct | — | Acquired | (price as of 2026-08-21) |
| March 31, 2023 | CYPH | A | 500,000 | — | — | 500,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Sept. 1, 2022 | CYPH | A | 200,000 | — | — | 200,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 31, 2022 | CYPH | A | 225,000 | — | — | 225,000 Direct | — | Acquired | (price as of 2026-08-21) |
| May 26, 2021 | CYPH | A | 30,000 | — | — | 30,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 26, 2021 | CYPH | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 26, 2021 | CYPH | A | 150,000 | — | — | 150,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 10, 2020 | CYPH | A | 75,000 | — | — | 75,000 Direct | — | Acquired | (price as of 2026-08-21) |
| April 9, 2020 | CYPH | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | CMPX | STOCK OPTION (RIGHT TO BUY) | COMMON STOCK (1,000,000) | $5.17 | Jan. 2, 2036 | 1,000,000 | Acquired |
| March 28, 2025 | CYPH | Restricted Stock Units | Common Stock (22,500) | — | — | 22,500 | Disposed |
| Oct. 2, 2024 | CYPH | Employee Stock Option (Right to Buy) | Common Stock (85,000) | $2.45 | Oct. 2, 2034 | 85,000 | Acquired |
| Jan. 29, 2024 | CYPH | Employee Stock Option (Right to Buy) | Common Stock (85,000) | $2.68 | Jan. 29, 2034 | 85,000 | Acquired |
| Jan. 26, 2024 | CYPH | Restricted Stock Units | Common Stock (5,000) | — | — | 5,000 | Disposed |
| Aug. 23, 2023 | CYPH | Employee Stock Option (Right to Buy) | Common Stock (70,000) | $2.21 | Aug. 23, 2033 | 70,000 | Acquired |
| March 31, 2023 | CYPH | Employee Stock Option (Right to Buy) | Common Stock (500,000) | $0.34 | March 31, 2033 | 500,000 | Acquired |
| Sept. 1, 2022 | CYPH | Employee Stock Option (Right to Buy) | Common Stock (200,000) | $1.43 | Aug. 31, 2032 | 200,000 | Acquired |
| Jan. 31, 2022 | CYPH | Restricted Stock Units | Common Stock (225,000) | — | — | 225,000 | Acquired |
| May 26, 2021 | CYPH | Employee Stock Option (Right to Buy) | Common Stock (30,000) | $1.62 | May 25, 2031 | 30,000 | Acquired |
| Jan. 26, 2021 | CYPH | Restricted Stock Units | Common Stock (50,000) | — | — | 50,000 | Acquired |
| Jan. 26, 2021 | CYPH | Employee Stock Option (Right to Buy) | Common Stock (150,000) | $2.57 | Jan. 25, 2031 | 150,000 | Acquired |
| Aug. 10, 2020 | CYPH | Stock Option (Right to Buy) | Common Stock (75,000) | $1.97 | Aug. 9, 2030 | 75,000 | Acquired |
| April 9, 2020 | CYPH | Stock Option (Right to Buy) | Common Stock (50,000) | $1.69 | April 9, 2030 | 50,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (8,053) | 8,053 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (61) | 61 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (2,517) | 2,517 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (2,814) | 2,814 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (69,130) | 69,130 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (17,000) | 17,000 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (75,000) | 75,000 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (20,000) | 20,000 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (20,000) | 20,000 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (90,000) | 90,000 | Direct |
| April 6, 2020 | CYPH | Employee Stock Option (Right to Buy)→ Common Stock (150,000) | 150,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CYPH
Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $520,833 | — | $0 | $349,535 | $208,333 | — | $54,489 | $1,133,190 |
| 2021 | $437,143 | — | $128,500 | $274,092 | $209,829 | — | $44,247 | $1,093,811 |
| 2020 | $405,719 | — | — | $426,875 | $170,402 | — | $40,924 | $1,043,920 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.